Drawing for NATRAMED

USPTO serial 75347679

NATRAMED

Reviewed by CopyMark Law Group

Reg. 2312867Status 710
Filing date
Status date
Registration date
Feb 1, 2000
Examiner
SNAPP, TINA LOUISE
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with NATRAMED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JAMES W MCKEE

JAMES W MCKEE FAY SHARPE BEALL FAGAN MINNICH & MCKEE1100 SUPERIOR AVE STE 700CLEVELAND, OH 44114-2518UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005nutritional and health aids and supplements, namely, food supplements providing a source of vitamins and/or minerals and/or proteins and/or essential fatty acids; digestant preparations, namely, nutritional ingredients for improving digestion; intestinal florafoods; liver, iron and yeast preparations and/or compounds for use as hematinic supplements; dulse, namely, a nutritional seaweed supplement; chlorophyll preparations, namely, breath fresheners and enhancers; decongestants; sleeping pills, powders and tablets; capsules and liquids comprising herb preparations derived from or containing herbs for use as sleeping pills, diuretics, laxatives and decongestants; vitamins; mineral supplements; protein and fatty acid dietary supplements; and relaxant pills, powders, tablets, capsules and liquidsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2006C8..CANCELLED SEC. 8 (6-YR)—
May 16, 2006CFITCASE FILE IN TICRS—
Feb 1, 2000R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 9, 1999PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 8, 1999NPUBNOTICE OF PUBLICATION—
Jun 29, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 11, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 11, 1998CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 13, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 1998CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 1998DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance